Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis MARKET DYNAMICS Stringent cost and payer controls OPPORTUNITIES Impact Level Increasing studies on oral GLP-1 Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis Rapid expansion of manufacturing capacity is driving growth across the pharmaceutical market, especially for high-demand drugs like GLP-1 analogs
Medicaid allows states to decide which medicines on their drug lists are preferred or non-preferred, and states can use these out-of-pocket requirements to push patients toward their preferredtypically less expensivemedications
Phentermine compared to tirzepatide and phentermine compared to semaglutide highlight the differences between appetite suppressant classes
As popularity and demand continue to rise for GLP-1s, so do costs on both a per-unit and total-spend basis
US$ 21.54
US$ 20.40
US$ 27.56
US$ 27.62
US$ 22.79
US$ 28.50
